Cellosaurus logo
expasy logo

Cellosaurus KMOE-2 (CVCL_1332)

[Text version]
Cell line name KMOE-2
Synonyms KMOE2; Kmoe2
Accession CVCL_1332
Resource Identification Initiative To cite this cell line use: KMOE-2 (RRID:CVCL_1332)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Population: Japanese.
Doubling time: 24.2 hours (PubMed=6949905); ~40-50 hours (DSMZ=ACC-37).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations
  • Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (Cosmic-CLP=907280; DepMap=ACH-002258).
  • Mutation; HGNC; 11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Homozygous (Cosmic-CLP=907280; DepMap=ACH-002258).
Genome ancestry Source: PubMed=30894373

Origin% genome
African0.41
Native American0.02
East Asian, North78.12
East Asian, South19.8
South Asian1.43
European, North0.23
European, South0
Disease Erythroleukemia (NCIt: C7152)
Acute erythroid leukemia (ORDO: Orphanet_318)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_UF71 (KMOE-2/05)
Originate from same individual CVCL_W022 ! KMOE-1
Sex of cell Female
Age at sampling 2Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP=907280; DSMZ=ACC-37

Markers:
AmelogeninX
CSF1PO9,12
D2S133820,25
D3S135815,16
D5S8188,10
D7S82010
D8S117913,16
D13S3178,11
D16S5399,11
D18S5118,22
D19S43313,16
D21S1128,29
FGA19,22
Penta D11,12
Penta E11,12
TH016,9
TPOX9
vWA14,17

Run an STR similarity search on this cell line
Publications

PubMed=6949905; DOI=10.1007/BF00410534
Okano H., Okamura J., Yagawa K., Tasaka H., Motomura S.
Human erythroid cell lines derived from a patient with acute erythremia.
J. Cancer Res. Clin. Oncol. 102:49-55(1981)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113
Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line collections (Providers) DSMZ; ACC-37
Cell line databases/resources CLO; CLO_0007114
CLDB; cl3034
cancercelllines; CVCL_1332
Cell_Model_Passport; SIDM01019
Cosmic-CLP; 907280
DepMap; ACH-002258
DSMZCellDive; ACC-37
LINCS_LDP; LCL-1058
Biological sample resources BioSample; SAMN03473322
Chemistry resources ChEMBL-Cells; CHEMBL3308236
ChEMBL-Targets; CHEMBL2366347
GDSC; 907280
PharmacoDB; KMOE2_757_2019
PubChem_Cell_line; CVCL_1332
Encyclopedic resources Wikidata; Q54900132
Gene expression databases ArrayExpress; E-MTAB-783
ArrayExpress; E-MTAB-3610
GEO; GSM1446748
GEO; GSM1669991
Polymorphism and mutation databases Cosmic; 787445
Cosmic; 907280
Cosmic; 975262
Cosmic; 1012079
Cosmic; 1465969
Cosmic; 2131542
Cosmic; 2306213
IARC_TP53; 21434
Proteomic databases PRIDE; PXD030304
Sequence databases EGA; EGAS00001000978
Entry history
Entry creation04-Apr-2012
Last entry update02-May-2024
Version number39